OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
100
Results
Show all
Save search
Copy query
Show results for
Unknown
(100)
Publication Date
Release Date
2018
(33)
2022
(9)
2024
(6)
2021
(6)
2025
(5)
2023
(5)
2020
(5)
2014
(4)
2013
(4)
2010
(4)
2008
(4)
2019
(3)
2016
(3)
2015
(3)
2017
(2)
2012
(2)
2026
(1)
2011
(1)
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
Not available
S-EPMC9325449
|
biostudies-literature
Cite
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib.
Not available
S-EPMC8377516
|
biostudies-literature
Cite
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.
Not available
S-EPMC8280094
|
biostudies-literature
Cite
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer.
Not available
S-EPMC4714672
|
biostudies-literature
Cite
White matter hyperintensities on MRI in high-altitude U-2 pilots.
Not available
S-EPMC3776459
|
biostudies-literature
Cite
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Not available
S-EPMC10092751
|
biostudies-literature
Cite
SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation
Not available
S-EPMC7208240
|
biostudies-literature
Cite
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Not available
S-EPMC6089612
|
biostudies-literature
Cite
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
Not available
S-EPMC4177038
|
biostudies-literature
Cite
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
Not available
S-EPMC9332138
|
biostudies-literature
Cite
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets